Popat S, Hsia TC, Hung JY, Jung HA, et al. Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG). Oncologist 2022;27:255-265.
PMID: 35274704